J7674 HCPCS code: Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
J7674 is the HCPCS Level II code for methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg. In 2024 Medicare paid an average of $0.88 per service for J7674 across 64,098 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 100 per day on outpatient hospital claims. Medicare volume fell 6% from 2022 to 2024 (67,907 to 64,098 services). In 2024, about 283 clinicians billed Medicare for J7674 for 1,914 beneficiaries; Tennessee, Texas, Oklahoma accounted for 53% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2005-01-01 |
| Last action effective | 2005-01-01 |
Who bills J7674 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 283 |
| Medicare beneficiaries | 1,914 |
| States with claims | 20 |
| Share of services in top 3 states (Tennessee, Texas, Oklahoma) | 53% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7674, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 67,907 | 1,268 | $0.79 | $0.60 |
| 2023 | 67,408 | 1,898 | $0.78 | $0.61 |
| 2024 | 64,098 | 1,914 | $1.14 | $0.88 |
States with the most J7674 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Tennessee | 13,585 | $0.95 |
| Texas | 13,163 | $0.90 |
| Oklahoma | 4,922 | $0.94 |
| Alabama | 3,483 | $0.70 |
| Illinois | 3,415 | $0.91 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 100 | Prescribing Information |
| practitioner claims | 100 | Prescribing Information |
What changed for J7674
- 2005-01-01: J7674 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7674?
J7674 is the HCPCS Level II code for methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg. Short descriptor: "Methacholine chloride, neb".
How much does Medicare pay for J7674?
In 2024, the average Medicare payment was $0.88 per service (average allowed $1.14).
Does Medicare cover J7674?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J7674 can be billed per day?
100 on outpatient hospital claims; 100 on practitioner claims (NCCI medically unlikely edits).
Related J76 codes
- J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7674
- Watch J7674 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7674
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.